BioPorto A/S
BioPorto A/S
1,50 %
3,390 DKK
0,05
Kurs
3,390
Hög
3,400
Förändring
1,50 %
Låg
3,305
Uppdaterad
2019-07-19
Öppen
3,340
Factsheet for BioPorto A/S
Company Profile
Description
Bioporto A/S is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's segments include the NGAL Test, ELISA Human NGAL kits, ELISA Animal NGAL kits, ELISA MBL kits, Antibodies, and Other products and licenses. Bioporto generates majority of its revenues from Antibodies segment.
Key Stats
Website: http://www.bioporto.com
Headquarter country: Denmark
Employees: 25
Market Cap (at close 19-07-2019): DKK 593M
Fiscal Year Ends: december
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings 191,50 179,80
Forward Price/Earnings
Price/Free Cash Flow
Return on Assets -57,70 -55,50 -45,80 -24,90 -29,00
Return on Equity -67,80 -64,30 -51,40 -29,30 -36,10
Return on Invested Capital -67,60 -63,90 -51,20 -28,80 -36,50
Dividend


Dividend/Share:
Ex. Dividend Date:0001-01-01
Trailing Dividend Yield:
Payout Ratio:0,00
Date Currency Amount
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 26,02 25,16 20,72 20,38 18,71
Gross Profit 0,02 0,02 0,02 0,02 0,01
Gross Margin % 68,55% 72,54% 75,74% 75,95% 70,55%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA -41,00 -37,00 -24,00 -12,00 -15,00
Net income -38,00 -32,00 -23,00 -11,00 -13,00
Basic Earnings Per Share -0,24 -0,22 -0,17 -0,09 -0,11
Operating Income -0,04 -0,04 -0,03 -0,01 -0,02
Operating Margin % -160,60% -145,08% -120,88% -62,60% -81,56%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow -38,00 -29,00 -20,00 -17,00 -16,00
Capital Expenditures -1,00 0,00 0,00 -1,00 -1,00
Free Cash Flow -39,00 -29,00 -20,00 -17,00 -17,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets 62,64 62,98 47,57 47,32 35,78 51,31
Long Term Assets 3,56 2,62 3,07 1,68 1,46 0,53
Total Assets 66,20 65,60 50,64 48,99 37,24 51,84
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities 9,22 8,65 5,15 4,44 8,47 8,88
Long Term Liabilities 0,88 1,20 0,06
Total Liabilities 9,54 6,35 4,51
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings -109,14 -99,37 -97,89 -85,68 -89,84 -76,68
Treasury Stock 0,00 0,00 0,00 0,00 0,00 0,00
Total Stockholder Equity 56,20 56,07 44,29 44,49 28,69 42,86
Net Tangible Assets 54,82 54,44 42,33 43,93 28,49 42,86